Sobi Exits Nirsevimab Cost-Sharing Pact With AstraZeneca, Simplifies Royalty Deal With Sanofi

 
• By Joseph Haas
  
Businessman sinking in heap of documents and asking for help
Sobi says new agreements simplify rights pertaining to nirsevimab
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business